MKI67 and neoplasm: Consistent with the tumor growth delay, there was significant reduction in tumor cell proliferation 1 week after RTxSD, as well as after 2 or 3 weeks of RTxFR as measured by Ki67 immunohistochemistry (Figure 2C, Supplementary Figure S2).